Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Neutra's EPS for the twelve months ending Oct 31, 2018 was -$0.18. For fiscal 2021 it was $0.00. The highest annual figure on record is $0.00 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Jan 31, 2021 | $0.00 | – |
| FY2020 | Jan 31, 2020 | $0.00 | – |
| FY2019 | Jan 31, 2019 | -$0.16 | – |
| FY2018 | Jan 31, 2018 | -$0.10 | – |
| FY2017 | Jan 31, 2017 | -$0.41 | – |
| FY2016 | Jan 31, 2016 | -$1.25 | – |
| FY2015 | Jan 31, 2015 | -$3.36 | – |
| FY2014 | Jan 31, 2014 | -$6.50 | – |
| FY2013 | Jan 31, 2013 | -$8.00 | – |
| FY2012 | Jan 31, 2012 | -$7.50 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $0.00 | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $0.00 | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $0.00 | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $0.00 | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $0.00 | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $0.00 | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $0.00 | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $0.00 | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $0.00 | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$0.12 | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$0.02 | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$0.02 | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | -$0.02 | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$0.01 | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$0.03 | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$0.06 | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | -$0.13 | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | -$0.08 | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | -$0.08 | – |
| Q1 FY2017CQ1 2016 | Apr 30, 2016 | -$0.10 | – |
| Q4 FY2016CQ4 2015 | Jan 31, 2016 | -$0.44 | – |
| Q3 FY2016CQ3 2015 | Oct 31, 2015 | -$0.20 | – |
| Q2 FY2016CQ2 2015 | Jul 31, 2015 | -$0.19 | – |
| Q1 FY2016CQ1 2015 | Apr 30, 2015 | -$0.39 | – |
| Q4 FY2015CQ4 2014 | Jan 31, 2015 | -$0.59 | – |
| Q3 FY2015CQ3 2014 | Oct 31, 2014 | -$0.85 | – |
| Q2 FY2015CQ2 2014 | Jul 31, 2014 | -$1.00 | – |
| Q1 FY2015CQ1 2014 | Apr 30, 2014 | -$1.00 | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | -$1.59 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?